• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The Usefulness of Outpatient Pharmacy Services in Adjuvant Chemotherapy for Gastric Cancer].

作者信息

Horasawa Satoshi, Matsui Reiko, Kawasumi Kenji, Saito Shinichiro

机构信息

Dept. of Pharmacy, National Cancer Center Hospital East.

出版信息

Gan To Kagaku Ryoho. 2016 Sep;43(9):1091-5.

PMID:27628550
Abstract

Outpatient pharmacy services were established since June 2009 for educating about the signs and symptoms that required treatment, explaining how to receive an emergency service, improving a patient's adherence, and managing side effects. In this study, we evaluated the usefulness of one of our outpatient pharmacy services, which aims to help patients receiving adjuvant chemotherapy including S-1 monotherapy for gastric cancer. In total, 34 and 80 patients received S-1 monotherapy without or with the intervention of outpatient pharmacy services, respectively; additionally, the median ages of the former and latter were 68 and 65 years, respectively. The treatment completion rates(82.4% versus 67.5%)were similar between the 2 groups(odds ratio[OR]: 0.45, 95% confidence interval[CI]: 0.16-1.21, p=0.106). Their emergency visit rates were 23.5% and 8.8%(OR: 0.31, 95% Cl: 0.10-0.94, p<0.05). Emergency hospitalization was required for 8.8% and 0% of the population from each group(OR: 0.00, 95% CI: not significant, p<0.05). We suggest that outpatient pharmacy services are useful because they are likely to improve a patient's safety.

摘要

相似文献

1
[The Usefulness of Outpatient Pharmacy Services in Adjuvant Chemotherapy for Gastric Cancer].
Gan To Kagaku Ryoho. 2016 Sep;43(9):1091-5.
2
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.序贯紫杉醇联合替加氟和尿嘧啶(UFT)或 S-1 对比 UFT 或 S-1 单药作为 T4a/b 期胃癌辅助化疗(SAMIT):一项 3 期析因随机对照试验。
Lancet Oncol. 2014 Jul;15(8):886-93. doi: 10.1016/S1470-2045(14)70025-7. Epub 2014 Jun 18.
3
[Current status of adjuvant chemotherapy in patients with p-Stage II and p-Stage III gastric cancer].[Ⅱ期和Ⅲ期胃癌患者辅助化疗的现状]
Gan To Kagaku Ryoho. 2014 Aug;41(8):961-4.
4
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.S-1单药治疗难治的晚期胃癌患者二线伊立替康联合顺铂与单用伊立替康的随机III期试验:TRICS试验
Eur J Cancer. 2015 May;51(7):808-16. doi: 10.1016/j.ejca.2015.02.009. Epub 2015 Mar 18.
5
Phase I study of S-1 plus fractional cisplatin as adjuvant chemotherapy for advanced gastric cancer in an outpatient setting (KOGC-03).
Anticancer Res. 2015 Jan;35(1):467-71.
6
Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.辅助化疗 S-1 对韩国可切除的晚期胃癌患者的安全性和可行性。
Cancer Chemother Pharmacol. 2012 Oct;70(4):523-9. doi: 10.1007/s00280-012-1935-6. Epub 2012 Aug 5.
7
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.一项药学服务项目对药物依从性、持续性、血压及低密度脂蛋白胆固醇的影响:一项随机对照试验
JAMA. 2006 Dec 6;296(21):2563-71. doi: 10.1001/jama.296.21.joc60162. Epub 2006 Nov 13.
8
The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer.门诊在不可切除或复发性胃癌患者化疗中的作用。
Jpn J Clin Oncol. 2007 Feb;37(2):96-101. doi: 10.1093/jjco/hyl145. Epub 2007 Feb 1.
9
Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer.晚期胃癌序贯门诊化疗的回顾性评估
Chemotherapy. 2007;53(3):226-32. doi: 10.1159/000100865. Epub 2007 Mar 14.
10
A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.氟嘧啶和/或顺铂辅助治疗后复发胃癌患者多西他赛和奥沙利铂联合治疗的 II 期研究:韩国癌症研究组方案 ST06-02。
Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72. doi: 10.1007/s00280-012-1956-1. Epub 2012 Aug 25.

引用本文的文献

1
A retrospective study comparing interventions by oncology and non-oncology pharmacists in outpatient chemotherapy.一项比较肿瘤学和非肿瘤学药师在门诊化疗中干预措施的回顾性研究。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1371. doi: 10.1002/cnr2.1371. Epub 2021 Mar 19.